Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio
Go back to Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio| (NASDAQ: IMDX) | Delayed: 4.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.13 | 52 Week High | $ | |||
| Open | $4.13 | 52 Week Low | $ | |||
| Day High | $4.13 | P/E | N/A | |||
| Day Low | $4.13 | EPS | $ | |||
| Volume | 1,525 | |||||

